journal article·2024-05

0D Amplification Strategies Reshape Bone Interface Niches via Biointernalization Effects

Yuhao Yu, Juan Wang, Zhenyu Sun, Zehao Chen, Wei Xiong, Yamin Li, Wenguo Cui, Yunsu Chen

Advanced Functional Materials· Volume 34· Issue 22
Publisher page

Abstract

Abstract 0D biomaterials (0DBMs) can serve as carriers to enhance and extend the regulatory effects of biological cues they transport on cell fate via bacterial/mammalian cell internalization. However, accurately delivering and amplifying biosignals through 0DBMs remains challenging to cope with ecological niche destabilization induced by factors such as trauma or infection. Herein, the “zero‐dimensional amplification” approach is employed to develop a surface carboxylate carbon dot (CQD‐COOH) conjugated with a neutrophil constitutive peptide (LL‐37), resulting in the formation of a 0D peptide quantum dot (LQD). Hydrogel‐released LQDs, when internalized by bacteria, cause the bacteria to programmatically rupture and die, whereas LQDs internalized by mesenchymal stem cells (MSCs) activate the cellular CXCL12/CXCR4 signaling axis, which directs the stem cells to homing and anchor to the surface of the hydrogel coating. Notably, this strategy of “zero‐dimensional amplification” enables the antimicrobial performance of LL‐37 to be boosted approximately 1.3‐fold, significantly extending the transmission efficiency of biosignals. Meanwhile, 0D lipid nanoparticles (lipo‐NPs) with targeting function incorporated into the hydrogel could deliver the bio‐small molecule MK‐4 to MCSs and induce their endocytosis, further enhancing osseointegration. Thus, the hydrogel coating (HGLL) under this strategy can significantly remodel the ecological niche of the implant–bone interface in infected environment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Supramolecular Self-Assembly in Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Surgery Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine 600 Yishan Road Shanghai 200233 P. R. China

Department of Orthopedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (44)

Show source-provided references
1. 10.1002/anie.20230658310.1002/anie.202306583 ↗
2. 10.1016/j.apsb.2021.02.01910.1016/j.apsb.2021.02.019 ↗
3. 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
4. 10.1002/aic.1750710.1002/aic.17507 ↗
5. 10.1016/j.addr.2019.04.00810.1016/j.addr.2019.04.008 ↗
6. 10.1002/anie.20221734510.1002/anie.202217345 ↗
7. 10.1038/s41565-021-00929-w10.1038/s41565-021-00929-w ↗
8. 10.1016/j.scib.2017.12.01210.1016/j.scib.2017.12.012 ↗
9. 10.1016/j.stem.2012.02.01810.1016/j.stem.2012.02.018 ↗
10. 10.1016/j.engreg.2021.09.00510.1016/j.engreg.2021.09.005 ↗
11. 10.1002/SMMD.2023001410.1002/SMMD.20230014 ↗
12. Paul W. · J. Stem Cells · 2011 · 6 · 181
13. 10.1002/adfm.20230034110.1002/adfm.202300341 ↗
14. Vats M. · 2022 · 11
15. 10.1126/sciadv.adf864510.1126/sciadv.adf8645 ↗
16. 10.1038/s41467-021-27217-410.1038/s41467-021-27217-4 ↗
17. 10.1126/sciadv.aba572310.1126/sciadv.aba5723 ↗
18. 10.1038/nrendo.2014.23410.1038/nrendo.2014.234 ↗
19. 10.1038/s41467-021-21533-510.1038/s41467-021-21533-5 ↗
20. 10.1039/C9BM01158G10.1039/C9BM01158G ↗
21. 10.1016/j.addr.2018.06.02010.1016/j.addr.2018.06.020 ↗
22. 10.1002/chem.20120364110.1002/chem.201203641 ↗
23. 10.1016/j.carbon.2016.06.01710.1016/j.carbon.2016.06.017 ↗
24. 10.1016/j.msec.2016.12.08810.1016/j.msec.2016.12.088 ↗
25. 10.1016/j.engreg.2022.05.00210.1016/j.engreg.2022.05.002 ↗
26. 10.1021/acsbiomaterials.9b0028110.1021/acsbiomaterials.9b00281 ↗
27. 10.1002/SMMD.2022002410.1002/SMMD.20220024 ↗
28. 10.1016/j.actbio.2018.12.03110.1016/j.actbio.2018.12.031 ↗
29. 10.1016/j.bioactmat.2022.07.03110.1016/j.bioactmat.2022.07.031 ↗
30. 10.1016/j.jmbbm.2015.06.02310.1016/j.jmbbm.2015.06.023 ↗
31. 10.1039/C7BM00991G10.1039/C7BM00991G ↗
32. 10.1002/adma.20190434110.1002/adma.201904341 ↗
33. 10.1002/SMMD.2022000710.1002/SMMD.20220007 ↗
34. 10.1016/j.actbio.2018.09.05910.1016/j.actbio.2018.09.059 ↗
35. 10.1021/acsnano.2c0598010.1021/acsnano.2c05980 ↗
36. 10.1002/adma.20230018010.1002/adma.202300180 ↗
37. 10.1038/s41467-021-27816-110.1038/s41467-021-27816-1 ↗
38. 10.1016/j.cbi.2018.03.00210.1016/j.cbi.2018.03.002 ↗
39. Wang H. · 2021
40. 10.1038/s41467-022-30243-510.1038/s41467-022-30243-5 ↗
41. 10.1155/2015/58785710.1155/2015/587857 ↗
42. 10.1021/acsnano.0c0804510.1021/acsnano.0c08045 ↗
43. 10.1111/j.1474-9726.2008.00377.x10.1111/j.1474-9726.2008.00377.x ↗
44. 10.1021/acsbiomaterials.8b0109410.1021/acsbiomaterials.8b01094 ↗